Session 3: Molecular Epidemiology Introduction

Slides:



Advertisements
Similar presentations
Monitoring the impact of vaccination on rubella and CRS Susan E. Reef, MD 11 th Annual Meeting The Measles and Rubella Initiative Sept. 19, 2012.
Advertisements

Epidemiology J Endemic, epidemic or pandemic? Disease prevention
A global partnership to stop measles & rubella Competent and Sustainable Global Laboratory Surveillance for Measles and Rubella is Provided by the WHO.
Polio Eradication Dr Marvin Hsiao Division of Medical Virology NHLS/UCT/Groote Schuur Hospital.
Lisa Grohskopf, MD, MPH Medical Officer Influenza Division Centers for Disease Control and Prevention U.S. Influenza Surveillance National Center for Immunization.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
Virus Evolution Molecular Epidemiology of Viral Infections Jen-Ren Wang, Ph. D. 王貞仁 Dept. of Medical Laboratory Science and Biotechnology National Cheng.
Materials and Methods Abstract Conclusions Introduction 1. Korber B, et al. Br Med Bull 2001; 58: Rambaut A, et al. Nat. Rev. Genet. 2004; 5:
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
World Health Organization
HPAI in Indonesia Dr. Elly Sawitri Siregar Coordinator, HPAI Campaign Management Unit Directorate of Animal Health DGLS, MoA H5N1 HIGHLY PATHOGENIC AVIAN.
Influenza Surveillance at IRID Immunization and Respiratory Infections Division Centre for Infectious Disease Prevention & Control Public Health Agency.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
Surveillance Activities during Pandemic Phases Anne-Luise Winter APHEO-COMOH Workshop Toronto February 1, 2007.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
Summary Slide Presentation Are subtype differences important in HIV drug resistance? Lessells RJ, Katzenstein DK, de Oliveira T. Are subtype differences.
Palestine Bahrain Global Measles and Rubella Management Meeting Boubker Naouri March, 2011 Geneva, WHO HQ.
World Health Organization, Regional Office for The Western Pacific Regional Activities Report and Preparation for the Upcoming Influenza Seasons THE 3rd.
Laboratory Integration in Influenza Surveillance Dr Geethani Wickramasinghe NIC- Sri Lanka.
8 th Global Measles and Rubella LabNet Meeting, Sept 2010 Key Recommendations GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Salle B, WHO.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
Introduction for Basic Epidemiological Analysis for Surveillance Data National Center for Immunization & Respiratory Diseases Influenza Division.
David Featherstone EPI / IVB WHO/HQ Measles Partners Meeting September 2008 Washington Global Measles Rubella Laboratory Network: Update.
Influenza H1N1 Introduction. What is Influenza A H1N1?  Influenza virus  Family Orthomyxoviridae  2 important surface proteins  Haemagglutinin (H)
The New Influenza A/H1N1 Isabelle Thomas May 28-29, 2009 Brussels,
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
Human survivorship Developed Developing Bob May (2007), TREE 22:
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
Mumps and Mumps Vaccine
Human survivorship Developed Developing Bob May (2007), TREE 22:
1 Recent Global Development of Two Major Porcine Diseases - African Swine Fever and Porcine Epidemic Diarrhea - Dr Tomoko ISHIBASHI Deputy Regional Representative.
Accelerating Progress towards Measles and Rubella Elimination, June 2016, Hotel Royal, Geneva National Center for Immunization & Respiratory Diseases.
Accelerating progress towards MR elimination, |1 | Update from Regional Measles & Rubella Laboratory Network, African Region Hotel Royal, Geneva,
Accelerating Progress towards Measles and Rubella Elimination WHO Western Pacific Region UNICEF East Asia and Pacific Region 1 21 June 2016 Geneva, Switzerland.
Influenza Virologic Surveillance and Vaccine Strain Selection Xiyan Xu MD Deputy Director WHO Collaborating Center for Surveillance, Epidemiology and Control.
Response to the Yellow Fever Outbreak in the WHO African Region: What has been done? Dr Ambrose Talisuna, WHO-Regional Office for Africa-AFRO Brazzaville-Congo.
World Health Organization
Measles and Rubella Surveillance in the time of Zika: Brazil
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Status of the WHO measles and rubella laboratory manual
Innovations: Measles Programmatic Risk Assessments
Vaccine specific RT-PCR for measles (MeVA)
Evolution of rubella viruses following long term endemic circulation
Global Overview of Measles
Alberto Severini on behalf of the N.E.W working group
Molecular EQA for GMRLN: Year Two
53 Member States >900 million inhabitants WHO European Region
World Health Organization
MeaNS, RubeNS and a global update
Influenza Virus: Evolution in real time
World Health Organization
World Health Organization
Experience with the measles outbreak response fund
Division of Viral Hepatitis
Confirmed Rubella Cases in the Americas, 2013*
Bioinformatics for plant biosecurity and surveillance systems
ICAR-Directorate of Foot-and-mouth disease, Mukteswar, India
The Role of NICs in Influenza Surveillance
Confirmed measles cases following the
Planning for Pandemic Influenza
June 18 – July 10 July 29 – August 20 September 23 – October 2
Evolution and transmission in HIV
Maintaining Elimination in an Environment of Persistent Importation
National Immunization Conference, Dallas, TX
Samia Metwally, DVM, PhD (FAO)
Presentation transcript:

Session 3: Molecular Epidemiology Introduction Paul Rota Centers for Disease Control Accelerating Progress towards Measles and Rubella Elimination Hotel Royal, Geneva, Switzerland, 21-23 June 2016 *The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. National Center for Immunization & Respiratory Diseases Division of Viral Diseases

All vaccines strains are in genotype A Lessons Learned from > 20 years of Genetic Characterization of Measles Viruses: 1 All vaccines strains are in genotype A Wild-type viruses in genotype A no longer circulate Sequence information allowed development of RT-PCR based assays for rapid confirmation of vaccines reactions National Center for Immunization & Respiratory Diseases Division of Viral Diseases

Unlikely that antigenic drift will compromise vaccine efficacy Lessons Learned from > 20 years of Genetic Characterization of Measles Viruses: 2 No evidence for selective pressure on the H protein based on measurement of rates on nonsynonymous/synonymous amino acid substitutions Site directed mutagenesis of the measles H protein shows structural constraints needed for binding to SLAM and nectin-4 Unlikely that antigenic drift will compromise vaccine efficacy National Center for Immunization & Respiratory Diseases Division of Viral Diseases

Change in apparent geographic restriction of some genotypes Lessons Learned from > 20 years of Genetic Characterization of Measles Viruses: 3 Genetic characterization allows tracking of viral transmission pathways Extended sequencing windows will be needed to increase the resolution of molecular epidemiologic studies Change in apparent geographic restriction of some genotypes Genotype B3, once restricted to African countries, now has a global distribution Genotype D8, endemic in India, now has a global distribution Genotype H1, still endemic only in China National Center for Immunization & Respiratory Diseases Division of Viral Diseases

Lessons Learned from > 20 years of Genetic Characterization of Measles Viruses: 4 In countries that have eliminated measles, the pattern of genotypes reflects the sources of imported virus Lack of endemic genotype is an essential criterion for verification of elimination Countries with endemic measles have multiple, co circulating lineages of measles virus In countries where measles has been reintroduced, often only a single lineage is detected National Center for Immunization & Respiratory Diseases Division of Viral Diseases

11 Wild-type Genotypes Detected Since 2005: 6 Still Circulating 2006 2007 2008 2009 2010 2011 2012 2013 2014 B2   B3 D11 D4 D5 D6 D7 D8 D9 G3 H1 National Center for Immunization & Respiratory Diseases Division of Viral Diseases

Shift in genotypes over time in various regions Lessons Learned from > 20 years of Genetic Characterization of Measles Viruses: 5 There is an apparent decrease in genetic diversity of circulating measles viruses based on a decrease in the number of genotypes detected Shift in genotypes over time in various regions National Center for Immunization & Respiratory Diseases Division of Viral Diseases

What Does the Decreasing Genetic Diversity of Measles Viruses Tell Us? As the incidence of measles decreases the number of co-circulating lineages decreases. Can this decrease be used to measure the effectiveness of vaccination programs? The shift of genotypes and decrease in number of circulating genotypes suggests that measles transmission is interrupted frequently. However, as the number of measles susceptible individuals in increases, the country/region is reseeded by imported viruses. Though interruption of transmission has been suggested by epidemiologic data in the past, the more recent application of molecular epidemiology has helped to document these interruptions. Examples: Europe (C2, D6, D4, now D8 and B3) The Philippines, 2000-2015, interruption of genotype D3 National Center for Immunization & Respiratory Diseases Division of Viral Diseases

Measles Genotypes In the Philippines 2014-2015 Genotype B3 introduced, genotype B3 and D9 continues to circulate and cause outbreaks 2000-2004 Genotype D3 is the endemic genotype in the Philippines and D3 imports to other countries are traced to the Philippines 2007-2009 Genotypes D9 and G3 introduced and detected in outbreaks Number of measles cases 2004-2005 Measles campaign in 2004, no measles detected in 2005 Genotype D3 not detected globally after 2004 National Center for Immunization & Respiratory Diseases Division of Viral Diseases

Short Summary Genetic characterization of measles virus by the GMRLN has made substantial contributions to both the biology and evolution of measles viruses, and has become and integral prat of routine laboratory surveillance for measles The GMRLN needs to continue to build capacity for genetic characterization of both measles and rubella and to integrate new testing schemes and new technologies